… of sacubitril-valsartan compared to valsartan on cognitive … in patients with chronic heart
failure with preserved ejection … , a trial of sacubitril–valsartan versus valsartan in patients with …

… associated with the use of sacubitril/valsartan. In particular, potentially unfavorable effects
of … for heart failure, we aimed at exploring the impact of sacubitril/valsartan administration on …

… and chronic heart failure: the task force for the diagnosis and treatment of acute and chronic
heart failure … with the special contribution of the Heart Failure Association (HFA) of the ESC.  …

… analysis of the Valsartan Heart Failure Trial (Val-HeFT) was performed to evaluate the effects
of the angiotensin II receptor blocker, valsartan, in the patients with chronic heart failure (HF…

… The objective of this study was to test the hypothesis that the severity of left ventricular
remodeling predicts the response to treatment and outcomes in chronic heart failure. …

… heart failure, the Valsartan Heart Failure Trial has been designed to investigate the effect of
the angiotensin-receptor blocker, valsartan… York Heart Association classes II to IV heart failure…

Aims Optimizing medical cardiac treatment for sleep apnoea (SA) in patients with chronic
heart failure and reduced ejection fraction (HFrEF) is an expert Grade C recommendation …

… risks in patients with chronic heart failure. Our study, in … valsartan and no increased risk
associated with triple therapy in patients with myocardial infarction complicated by heart failure…

… chronic heart failure: the Task Force for the diagnosis and treatment of acute and chronic heart
failure of … Developed with the special contribution of the Heart Failure Association (HFA) of …

… In this post hoc analysis of the Valsartan Heart Failure Trial (Val-HeFT) 5 database, we
characterized the subjects who had improved their EF during the first 12 months of follow-up, …